Amarantus to Present Positive Alzheimer’s Disease Biomarker Data

Amarantus announced that its abstract titled “The LymPro® Assay: A Biomarker For Alzheimer’s Disease Using Blood Samples From Clinically Diagnosed Alzheimer’s Disease And Cognitively Intact Subjects” was accepted for poster presentation at the 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PDTM 2015) being held March 18-22, 2015, in Nice, France.  Read the press release at Globe Newswire

Published On: February 23rd, 2015Categories: Startup News
Feel free to share!